| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.00029 | 1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.00041 | 1 |